Related Experiment Video
Updated: May 4, 2026

Myocardial Infarction and Functional Outcome Assessment in Pigs
Published on: April 25, 2014
Neurologic complications of myocardial infarction
Moneera N Haque1, Robert S Dieter1
1Division of Cardiology, Department of Medicine, Loyola University Chicago, Stritch School of Medicine, Chicago, IL, USA.
Insights
Coronary artery disease is a leading cause of death. Treatments for cardiac conditions, including antiplatelet drugs and anticoagulants, can increase the risk of hemorrhagic stroke.
Area of Science:
- Cardiovascular medicine
- Neurology
- Pharmacology
Background:
- Coronary artery disease (CAD) is the primary cause of mortality globally.
- Cardiac conditions often lead to complications such as stroke.
- Therapies for cardiac disease, including anticoagulants and antiplatelet agents, are associated with an elevated risk of hemorrhagic stroke.
Purpose of the Study:
- To investigate the complex relationship between cardiac disease management and stroke risk.
- To analyze how common cardiac therapies influence the incidence of hemorrhagic stroke.
Main Methods:
- Review of epidemiological data on cardiac disease and stroke.
- Analysis of clinical trial outcomes for antiplatelet and anticoagulant therapies.
- Correlation studies examining treatment protocols and stroke complication rates.
Main Results:
- Cardiac disease, particularly CAD, remains a significant global health burden.
- Strokes are identified as a frequent complication in patients with cardiac conditions.
- Established treatments for cardiac disease demonstrably elevate the risk of hemorrhagic stroke.
Conclusions:
- Effective management of cardiac disease requires careful consideration of stroke risks.
- Further research is needed to balance the benefits of cardiac therapies against the risk of hemorrhagic stroke.
Abstract:
Cardiac disease, in particular coronary artery disease, is the leading cause of mortality in developed nations. Strokes can complicate cardiac disease - either as result of left ventricular dysfunction and associated thrombus formation or of therapy for the cardiac disease. Antiplatelet drugs and anticoagulants routinely used to treat cardiac disease increase the risk for hemorrhagic stroke.
Related Concept Videos
Myocarditis I: Introduction
Ischemic Stroke ll: Pathophysiology
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Introduction Cardiac Emergencies
Diphtheria
Acute Coronary Syndrome IV: Interprofessional Care

